These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26519962)

  • 1. [Preoperative assessment of patient candidate to prostate cancer surgery].
    Beauval JB; Mazerolles M; Salomon L; Soulié M
    Prog Urol; 2015 Nov; 25(15):947-65. PubMed ID: 26519962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional results and treatment of functional dysfunctions after radical prostatectomy].
    Salomon L; Droupy S; Yiou R; Soulié M
    Prog Urol; 2015 Nov; 25(15):1028-66. PubMed ID: 26519966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oncological outcomes of prostate cancer surgery].
    Soulié M; Salomon L
    Prog Urol; 2015 Nov; 25(15):1010-27. PubMed ID: 26519965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour characteristics, oncological and functional outcomes in patients aged ≥ 70 years undergoing radical prostatectomy.
    Kunz I; Musch M; Roggenbuck U; Klevecka V; Kroepfl D
    BJU Int; 2013 Mar; 111(3 Pt B):E24-9. PubMed ID: 22947135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgery of prostate cancer: Technical principles and perioperative complications].
    Salomon L; Rozet F; Soulié M
    Prog Urol; 2015 Nov; 25(15):966-98. PubMed ID: 26519963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatments around surgery of prostate cancer and surgery of recurrence].
    Salomon L; Ploussard G; Hennequin C; Richaud P; Soulié M
    Prog Urol; 2015 Nov; 25(15):1086-107. PubMed ID: 26519968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.
    Bratt O; Folkvaljon Y; Hjälm Eriksson M; Akre O; Carlsson S; Drevin L; Franck Lissbrant I; Makarov D; Loeb S; Stattin P
    Eur Urol; 2015 Jul; 68(1):53-8. PubMed ID: 25813688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Debulking surgery in the setting of very high-risk prostate cancer scenarios.
    Oderda M; Joniau S; Spahn M; Gontero P
    BJU Int; 2012 Sep; 110(6 Pt B):E192-8. PubMed ID: 22313515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preoperative endorectal MRI in prostate cancer: a monocentric retrospective cohort].
    de Vendin C; Eydant Y; Ecochard R; Lorin S; Lacroix B; Lardon R; Mottet N
    Prog Urol; 2013 Dec; 23(16):1412-8. PubMed ID: 24274946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative estimated glomerular filtration rate predicts overall mortality in patients undergoing radical prostatectomy.
    Tollefson MK; Boorjian SA; Gettman MT; Rangel LJ; Bergstralh EJ; Karnes RJ
    Urol Oncol; 2013 Nov; 31(8):1483-8. PubMed ID: 22578510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical prostatectomy for high-risk prostate cancer defined by preoperative criteria: oncologic follow-up in national multicenter study in 813 patients and assessment of easy-to-use prognostic substratification.
    Ploussard G; Masson-Lecomte A; Beauval JB; Ouzzane A; Bonniol R; Buge F; Fadli S; Rouprêt M; Rebillard X; Gaschignard N; Pfister C; Villers A; Soulié M; Salomon L;
    Urology; 2011 Sep; 78(3):607-13. PubMed ID: 21783233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.
    Auprich M; Bjartell A; Chun FK; de la Taille A; Freedland SJ; Haese A; Schalken J; Stenzl A; Tombal B; van der Poel H
    Eur Urol; 2011 Nov; 60(5):1045-54. PubMed ID: 21871709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis.
    Briganti A; Spahn M; Joniau S; Gontero P; Bianchi M; Kneitz B; Chun FK; Sun M; Graefen M; Abdollah F; Marchioro G; Frohenberg D; Giona S; Frea B; Karakiewicz PI; Montorsi F; Van Poppel H; Jeffrey Karnes R;
    Eur Urol; 2013 Apr; 63(4):693-701. PubMed ID: 22959192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life after radical prostatectomy depends on patient's age but not on comorbidities.
    Herkommer K; Schmid SC; Schulwitz H; Dinkel A; Klorek T; Hofer C; Ehrl D; Blaser R; Gschwend JE; Kron M
    Urol Oncol; 2015 Jun; 33(6):266.e1-7. PubMed ID: 25847625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
    Klein EA; Yousefi K; Haddad Z; Choeurng V; Buerki C; Stephenson AJ; Li J; Kattan MW; Magi-Galluzzi C; Davicioni E
    Eur Urol; 2015 Apr; 67(4):778-86. PubMed ID: 25466945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative oncologic and functional outcomes of prostate cancer surgery with other curative treatments].
    Soulié M; Salomon L
    Prog Urol; 2015 Nov; 25(15):1067-85. PubMed ID: 26519967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
    Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
    BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve-sparing approach during radical prostatectomy is strongly associated with the rate of postoperative urinary continence recovery.
    Suardi N; Moschini M; Gallina A; Gandaglia G; Abdollah F; Capitanio U; Bianchi M; Tutolo M; Passoni N; Salonia A; Hedlund P; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2013 May; 111(5):717-22. PubMed ID: 22726993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.
    Tamblyn DJ; Chopra S; Yu C; Kattan MW; Pinnock C; Kopsaftis T
    BJU Int; 2011 Nov; 108 Suppl 2():51-6. PubMed ID: 22085129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.